Recent findings in mouse models for human atopic dermatitis

Experimental Animals

Volumn 61, Issue 2, 2012, Pages 77-84

  Tanaka, Akane ^a   Amagai, Yosuke ^a   Oida, Kumiko ^a   Matsuda, Hiroshi ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Atopic dermatitis; Immune response; Itch; Skin barrier

Indexed keywords

ATOPIC DERMATITIS; CLINICAL FEATURE; DISEASE MODEL; EXPERIMENTAL MOUSE; HISTOPATHOLOGY; IMMUNOMODULATION; NONHUMAN; REVIEW; SKIN ALLERGY; SKIN PRURITUS; TH1 TH2 BALANCE; TRANSGENIC MOUSE;

ANIMALS; ANTIPRURITICS; BEHAVIOR, ANIMAL; DENDRITIC CELLS; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOMODULATION; MAST CELLS; MICE; MICE, TRANSGENIC; PRURITUS; SPECIES SPECIFICITY; TH2 CELLS;

ANIMALIA; MUS;

EID: 84861466366     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.61.77     Document Type: Review

References (32)

1. Aioi, A., Tonogaito, H., Suto, H., Hamada, K., Ra, C., Ogawa, H., Maibach, H., and Matsuda, H. 2001. Impairment of skin barrier function in NC/NgaTnd mice as a possible model for atopic dermatitis. Br. J. Dermatol. 144: 12-18. [Medline] [CrossRef]
2. Bieber, T. 2008. Atopic dermatitis. N. Engl. J. Med. 358: 1483-1494. [Medline] [CrossRef]
3. Elias, P.M. and Schmuth, M. 2009. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr. Opin. Allergy Clin. Immunol. 9: 437-446. [Medline] [CrossRef]
4. Grimstad, O., Sawanobori, Y., Vestergaard, C., Bilsborough, J., Olsen, U.B., Gronhoj-Larsen, C., and Matsushima, K. 2009. Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis. Exp. Dermatol. 18: 35-43. [Medline] [CrossRef]
5. Hattori, K., Nishikawa, M., Watcharanurak, K., Ikoma, A., Kabashima, K., Toyota, H., Takahashi, Y., Takahashi, R., Watanabe, Y., and Takakura, Y. 2010. Sustained exogenous expression of therapeutic levels of IFN-γ ameliorates atopic dermatitis in NC/Nga mice via Th1 polarization. J. Immunol. 184: 2729-2735. [Medline] [CrossRef]
6. Huang, C.H., Kuo, I.C., Xu, H., Lee, Y.S., and Chua, K.Y. 2003. Mite allergen induces allergic dermatitis with concomitant neurogenic inflammation in mouse. J. Invest. Dermatol. 121: 289-293. [Medline] [CrossRef]
7. Jung, K., Tanaka, A., Fujita, H., Matsuda, A., Oida, K., Karasawa, K., Okamoto, N., Ohmori, K., Jee, Y., Shin, T., and Matsuda, H. 2011. Peroxisome proliferator-activated receptor ã-mediated suppression of dendritic cell function prevents the onset of atopic dermatitis in NC/Tnd mice. J. Allergy Clin. Immunol. 127: 420-429. [Medline] [CrossRef]
8. Maekawa, S. and Ovary, Z. 1984. Correlation of murine anti- dinitrophenyl antibody content as determined by ELISA, passive cutaneous anaphylaxis and passive hemolysis. J. Immunol. Methods 71: 229-239. [Medline] [CrossRef]
9. Matsuda, H., Watanabe, N., Geba, G.P., Sperl, J., Tsudzuki, M., Hiroi, J., Matsumoto, M., Ushio, H., Saito, S., Askenase, P.W., and Ra, C. 1997. Development of atopic dermatitislike skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol. 9: 461-466. [Medline] [CrossRef]
10. Matsumoto, K., Mizukoshi, K., Oyobikawa, M., Ohshima, H., and Tagami, H. 2004. Establishment of an atopic dermatitis-like skin model in a hairless mouse by repeated elicitation of contact hypersensitivity that enables to conduct functional analyses of the stratum corneum with various non-invasive biophysical instruments. Skin Res. Technol. 10: 122-129. [Medline] [CrossRef]
11. Matsumoto, M., Itakura, A., Tanaka, A., Fujisawa, C., and Matsuda, H. 2001. Inability of IL-12 to down-regulate IgE synthesis due to defective production of IFN-γ in atopic NC/Nga mice. J. Immunol. 167: 5955-5962. [Medline]
12. Matsumoto, M., Ra, C., Kawamoto, K., Sato, H., Itakura, A., Sawada, J., Ushio, H., Suto, H., Mitsuishi, K., Hikasa, Y., and Matsuda, H. 1999. IgE hyperproduction through enhanced tyrosine phosphorylaion of Janus kinase 3 in NC/Ngamice, a model for human atopic dermatitis. J. Immunol. 162: 1056-1063. [Medline]
13. Moniaga, C.S., Egawa, G., Kawasaki, H., Hara-Chikuma, M., Honda, T., Tanizaki, H., Nakajima, S., Otsuka, A., Matsuoka, H., Kubo, A., Sakabe, J., Tokura, Y., Miyachi, Y., Amagai, M., and Kabashima, K. 2010. Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with dermatophagoides pteronyssinus extract. Am. J. Pathol. 176: 2385-2393. [Medline] [CrossRef]
14. Nagelkerken, L., Verzaal, P., Lagerweij, T., Persoon-Deen, C., Berbee, J.F., Prens, E.P., Havekes, L.M., and Oranje, A.P. 2008. Development of atopic dermatitis in mice transgenic for human apolipoprotein C1. J. Invest. Dermatol. 128: 1165-1172. [Medline] [CrossRef]
15. Niebuhr, M., Lutat, C., Sigel, S., and Werfel, T. 2009. Impaired TLR-2 expression and TLR-2-mediated cytokine secretion in macrophages from patients with atopic dermatitis. Allergy 64: 1580-1587. [Medline] [CrossRef]
16. Oyoshi, M.K., Murphy, G.F., and Geha, R.S. 2009. Filaggrin deficient mice exhibit Th17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. J. Allergy Clin. Immunol. 124: 485-493. [Medline] [CrossRef]
17. Palmer, C.N., Irvine, A.D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S.P., Goudie, D.R., Sandilands, A., Campbell, L.E., Smith, F.J., O'Regan, G.M., Watson, R.M., Cecil, J.E., Bale, S.J., Compton, J.G., DiGiovanna, J.J., Fleckman, P., Lewis-Jones, S., Arseculeratne, G., Sergeant, A., Munro, C.S., El Houate, B., McElreavey, K., Halkjaer, L.B., Bisgaard, H., Mukhopadhyay, S., and McLean, W.H. 2006. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 38: 441-446. [Medline] [CrossRef]
18. Ratzinger, G., Stoitzner, P., Ebner, S., Lutz, M.B., Layton, G.T., Rainer, C., Senior, R.M., Shipley, J.M., Fritsch, P., Schuler, G., and Romani, N. 2002. Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J. Immunol. 168: 4361-4371. [Medline]
19. Spergel, J.M., Mizoguchi, E., Oettgen, H., Bhan, A.K., and Geha, R.S. 1999. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J. Clin. Invest. 103: 1103-1111. [Medline] [CrossRef]
20. Sun, Y.G. and Chen, Z.F. 2007. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature 448: 700-703. [Medline] [CrossRef]
21. Takada, T., Shitara, H., Matsuoka, K., Kojima, E., Ishii, R., Kikkawa, Y., Taya, C., Karasuyama, H., Kohno, K., and Yonekawa, H. 2008. A novel hairless mouse model on an atopic dermatitis-prone genetic background generated by receptormediated transgenesis. Transgenic Res. 17: 1155-1162. [Medline] [CrossRef]
22. Takano, N., Sakurai, T., Ohashi, Y., and Kurachi, M. 2007. Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC/Nga mouse atopic dermatitis model. Br. J. Dermatol. 156: 241-246. [Medline] [Cross-Ref]
23. Tanaka, A., Muto, S., Jung, K., Itai, A., and Matsuda, H. 2007. Topical application with a new NF-êB inhibitor improves atopic dermatitis in NC/NgaTnd mice. J. Invest. Dermatol. 127: 855-863. [Medline] [CrossRef]
24. Thepen, T., Langeveld-Wildschut, E.G., Bihari, I.C., van Wichen, D.F., van Reijsen, F.C., Mudde, G.C., and Bruijnzeel-Koomen, C.A. 1996. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J. Allergy Clin. Immunol. 97: 828-837. [Medline] [CrossRef]
25. Tominaga, M., Ogawa, H., and Takamori, K. 2008. Decreased production of semaphorin 3A in the lesional skin of atopic dermatitis. Br. J. Dermatol. 158: 842-844. [Medline] [CrossRef]
26. Tominaga, M., Ogawa, H., and Takamori, K. 2009. Histological characterization of cutaneous nerve fibers containing gastrin-releasing peptide in NC/Nga mice: an atopic dermatitis model. J. Invest. Dermatol. 129: 2901-2905. [Medline] [CrossRef]
27. Tominaga, M., Tengara, S., Kamo, A., Ogawa, H., and Takamori, K. 2009. Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis. J. Dermatol. Sci. 55: 40-46. [Medline] [CrossRef]
28. Vestergaard, C., Yoneyama, H., Murai, M., Nakamura, K., Tamaki, K., Terashima, Y., Imai, T., Yoshie, O., Irimura, T., Mizutani, H., and Matsushima, K. 1999. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J. Clin. Invest. 104: 1097-1105. [Medline] [CrossRef]
29. Watanabe, O., Natori, K., Tamari, M., Shiomoto, Y., Kubo, S., and Nakamura, Y. 1999. Significantly elevated expression of PF4 (platelet factor 4) and eotaxin in the NOA mouse, a model for atopic dermatitis. J. Hum. Genet. 44: 173-176. [Medline] [CrossRef]
30. Yagi, R., Nagai, H., Iigo, Y., Akimoto, T., Arai, T., and Kubo, M. 2002. Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. J. Immunol. 168: 2020-2027. [Medline]
31. Yamaguchi, J., Nakamura, F., Aihara, M., Yamashita, N., Usui, H., Hida, T., Takei, K., Nagashima, Y., Ikezawa, Z., and Goshima, Y. 2008. Semaphorin3A alleviates skin lesions and scratching behavior in NC/Nga mice, an atopic dermatitis model. J. Invest. Dermatol. 128: 2842-2849. [Medline] [CrossRef]
32. Yoo, J., Omori, M., Gyarmati, D., Zhou, B., Aye, T., Brewer, A., Comeau, M.R., Campbell, D.J., and Ziegler, S.F. 2005. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J. Exp. Med. 202: 541-549. [Medline] [CrossRef]